What America's Corporations Can Do To Tackle Alzheimer's

Alzheimer's is common, costly and harms patients and their caregivers, but there are no effective treatments to slow the disease. This is bad news for companies. Caregivers are absent and distracted employees. Fortunately, companies can accelerate the pace of studies to discover treatments.